Creafund Mergers and Acquisitions Summary

Growth Capital Firm Profile

In the last 3 years, Creafund has acquired 2 companies. It has also invested in 3 others.

Creafund’s most common sectors for investment areconsumer products (17%) and life science (17%) . The Firm’s most common investment types include buyout (lbo, mbo, mbi) (25%) and growth capital (25%). In total, Creafund has invested in 3 different countries. Its largest (disclosed) acquisition occurred in 2020 when it acquired Vision Healthcare N.V. for $344M.

In the last 3 years, Creafund has exited 1 company. The Firm’s most common exit type is trade sale (50%).

Join Mergr to view Creafund’s full profile and discover more small growth capital firm investors just like it.

M&A Summary

  • M&A Total Activity14
    • M&A Buy Activity12
    • M&A Sell Activity2
  • Total Sectors Invested 9
  • Total Countries Invested 3
  • M&A Buy/Sell Connections 2
  • M&A Advisors 2

Creafund

Creafund Asset Management NV

Kapitein Maenhoutstraat 77 B,
Sint-Martens-Latem, 9830
Belgium
+32 9 272 62 00
www.creafund.be
assistant@creafund.be

Creafund is a private holding company that looks to acquire majority stakes in mature Belgian companies. Creafund takes majority stakes of between €5 and €25m in Belgian SMEs, being companies with EBITDA of between €2.5m and €25m, alongside entrepreneurs, family shareholders, and management. Prospective transaction situations include growth capital financings, buyouts, and consolidations. Creafund was formed in 2001 and is based in Sint-Martens-Latem, Belgium.


Investment Criteria

Sectors of Interest: Building Materials, Business Services, Construction, Consumer Products, Life Science, Manufacturing, Packaging, Semiconductors, Transportation

Target Transaction Types: Buyout (LBO, MBO, MBI), Consolidation, Divestiture, Growth Capital, Secondary Buyout, Stake Purchase

Geographic Preferences: Western Europe

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA 3 25
Investment Size 5 25
Enterprise Value 20 100
values in millions of EUR

M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (1.4/yr) # 5 2 4 1 - - 12
vol $344M $344M
Sell (0.2/yr) # 1 - - 1 - - 2
  14

Most Recent M&A

Company Date Value Type
Coeman Packaging 2022-06-03 - Growth Capital
Waregem, Belgium · www.coeman.be
Aalterpaint bvba 2022-05-31 - Secondary Sale
Lakeland, Belgium · www.aalterpaint.be
Sitra Group 2021-12-06 - Stake Purchase
Ypres, Belgium · www.sitra-group.com
Planet Group 2021-11-30 - Stake Purchase
Sint-Denijs-Westrem, Belgium · www.planet-group.com
Sofics 2021-09-01 - Recapitalization
Aalter, Belgium · www.sofics.com
Cooper Consumer Health SAS 2021-03-12 - Secondary Buyout
Paris, France · www.cooperconsumerhealth.eu
Real Corp., NV 2020-07-01 - Buyout (LBO, MBO, MBI)
Sint-Gillis-Waas, Italy · www.real-corp.be
Vision Healthcare N.V. 2020-06-01 344M EUR Divestiture
Kortrijk, Belgium · www.visionhealthcare.eu
Mylène nv 2019-01-04 - Trade Sale
Heist-op-den-Berg, Belgium · www.mylene.eu
Diresco NV 2018-01-01 - Buyout (LBO, MBO, MBI)
Oudsbergen, Belgium · www.diresco.be
View All >>

Portfolio M&A

Company Acquired Add-On/Sale Date #
Cooper Consumer Health SAS 2021-03-12 Viatris - Over the Counter (OTC) Business 2024-07-03 2
Paris, France · www.cooperconsumerhealth.eu Canonsburg, Pennsylvania
Vision Healthcare N.V. 2020-06-01 NaturaMed Pharma AS 2020-12-21 4
Kortrijk, Belgium · www.visionhealthcare.eu Drammen, Netherlands · www.naturamed-pharma.no

M&A by Sector

Sector Current # Value All-time # Value
Consumer Products 1 (9%) 344M (100%) 2 (17%) 344M (100%)
Life Science 2 (18%) - 2 (17%) -
Packaging 2 (18%) - 2 (17%) -
Building Materials 1 (9%) - 1 (8%) -
Construction 1 (9%) - 1 (8%) -
Metals/Mining 1 (9%) - 1 (8%) -
Semiconductors 1 (9%) - 1 (8%) -
Staffing 1 (9%) - 1 (8%) -
Transportation 1 (9%) - 1 (8%) -
Total 11 $344M 12 $344M

Acquisitions By Geo

State/Country Current # Value All-time # Value
Belgium 8 (73%) 344M (100%) 9 (75%) 344M (100%)
France 2 (18%) - 2 (17%) -
Italy 1 (9%) - 1 (8%) -
Total 11 $344M 12 $344M

Acquisitions by Deal Type

Type Current # Value All-time # Value
Buyout (LBO, MBO, MBI) 2 (18%) - 3 (25%) -
Growth Capital 3 (27%) - 3 (25%) -
Stake Purchase 3 (27%) - 3 (25%) -
Divestiture 1 (9%) 344M (100%) 1 (8%) 344M (100%)
Recapitalization 1 (9%) - 1 (8%) -
Secondary Buyout 1 (9%) - 1 (8%) -
Total 11 $344M 12 $344M

Exits by Deal Type

Type Total # Value
Secondary Sale 1 (50%) -
Trade Sale 1 (50%) -
Total 2 -

Top M&A Advisors

Financial Deals
Lincoln International
 1
Legal Deals
Eubelius
 1

Deal Values

buy # Total
$100M to $1B 1 $344M
TOTAL $344M
Largest Vision Healthcare N.V.
$344M (2020-06-01)

M&A Connections

Deals
Acquired from
Investor(s)
8%
1 (8%)
Strategic(s)
8%
1 (8%)
Exited to
Investor(s)
50%
1 (50%)
Strategic(s)
50%
1 (50%)

Investor Summary

Investor Type

Growth Capital Firm

Size

Small

PE Assets

100M EUR

Established

2001

Specialist/Generalist

Generalist

Leadership

Herman Wielfaert

CEO

Gino Schepens

Managing Director

Kenneth Depuydt

Investment Director

Ruth De Wulf

Investment Director

FAQ

When was Creafund founded?

Creafund was founded in 2001.

What type of investor is Creafund?

Creafund is a growth capital firm.

Where is Creafund headquartered?

Creafund is headquartered in Sint-Martens-Latem, Belgium.

How much capital does Creafund have under management?

Creafund has 100M EUR under management.

 Subscribe to unlock this and 209,130
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Mergr

Product

Company

Legal